Par Formulations Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Par Formulations General Information

Description

Manufacturer of generic drugs. The company is engaged in the production of solid oral dosage generic pharmaceuticals for the United States and other regulated markets. The company also provides contract research and development services.

Contact Information

Formerly Known As
Novel Therapeutics, Edict Pharmaceuticals
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • New No. 1/58, Pudupakkam Main Road
  • Kelambakkam, 603103
  • India
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Par Formulations Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Par Formulations‘s full profile, request access.

Request a free trial

Par Formulations Executive Team (2)

Name Title Board Seat Contact Info
Jaganathan Jayaseelan President
To view Par Formulations’s complete executive team members history, request access »

Par Formulations Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Par Formulations‘s full profile, request access.

Request a free trial